Effects of isolated GH deficiency on adipose tissue, feeding and adipokines in mice

Growth Hormone and IGF Research

Volumn 23, Issue 6, 2013, Pages 237-242

  Recinella, Lucia ^a   Shohreh, Rugia ^a   Salvatori, Roberto ^b   Orlando, Giustino ^a   Vacca, Michele ^a   Brunetti, Luigi ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adiponectin; Food intake; Growth hormone releasing hormone knockout; Intra abdominal fat; Leptin; Subcutaneous fat; Visfatin

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; LEPTIN; MESSENGER RNA; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;

ABDOMINAL FAT; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; BODY HEIGHT; BODY WEIGHT; CONTROLLED STUDY; FOOD INTAKE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASING HORMONE GENE; MALE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADIPONECTIN; FOOD INTAKE; GROWTH HORMONE-RELEASING HORMONE KNOCKOUT; INTRA-ABDOMINAL FAT; LEPTIN; SUBCUTANEOUS FAT; VISFATIN;

ADIPOKINES; ADIPOSE TISSUE; ANIMALS; DWARFISM, PITUITARY; EATING; GROWTH HORMONE-RELEASING HORMONE; HETEROZYGOTE; HOMOZYGOTE; LEPTIN; MALE; MICE; MICE, KNOCKOUT; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84886098345     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2013.08.004     Document Type: Article

References (60)

1. Le Roith D., Bondy C., Yakar S., Liu J.L., Butler A. The somatomedin hypothesis: 2001. Endocr. Rev. 2001, 22:53-74.
2. Goodman H.M., Schwartz Y., Tai L.R., Gorin E. Actions of growth hormone on adipose tissue: possible involvement of autocrine or paracrine factors. Acta Paediatr. Scand. Suppl. 1990, 367:132-136.
3. Richelsen B., Pedersen S.B., Børglum J.D., Møller-Pedersen T., Jørgensen J., Jørgensen J.O. Growth hormone treatment of obese women for 5wk: effect on body composition and adipose tissue LPL activity. Am. J. Physiol. 1994, 266:E211-E216.
4. Richelsen B. Action of growth hormone in adipose tissue. Horm. Res. 1997, 48(Suppl. 5):105-110.
5. O'Sullivan A.J., Kelly J.J., Hoffman D.M., Freund J., Ho K.K. Body composition and energy expenditure in acromegaly. J. Clin. Endocrinol. Metab. 1994, 78:381-386.
6. Berryman D.E., List E.O., Coschigano K.T., Behar K., Kim J.K., Kopchick J.J. Comparing adiposity profiles in three mouse models with altered GH signalling. Growth Horm. IGF Res. 2004, 14:309-318.
7. Eisen E.J., Peterson C.B., Parker I.J., Murray J.D. Effects of zinc ion concentration on growth, fat content and reproduction in oMT1a-oGH transgenic mice. Growth Dev. Aging 1998, 62:173-186.
8. Frick F., Bohlooly-Y M., Lindén D., et al. Long-term growth hormone excess induces marked alterations in lipoprotein metabolism in mice. Am. J. Physiol. Endocrinol. Metab. 2001, 281:E1230-E1239.
9. Hoffman D.M., O'Sullivan A.J., Freund J., Ho K.K. Adults with growth hormone deficiency have abnormal body composition but normal energy metabolism. J. Clin. Endocrinol. Metab. 1995, 80:72-77.
10. Leger J., Carel C., Legrand I., Paulsen A., Hassan M., Czernichow P. Magnetic resonance imaging evaluation of adipose tissue and muscle tissue mass in children with growth hormone (GH) deficiency, Turner's syndrome, and intrauterine growth retardation during the first year of treatment with GH. J. Clin. Endocrinol. Metab. 1994, 78:904-909.
11. Hoffman A.R., Kuntze J.E., Baptista J., et al. Growth hormone (GH) replacement therapy in adult-onset gh deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial. J. Clin. Endocrinol. Metab. 2004, 89:2048-2056.
12. Donahue L.R., Beamer W.G. Growth hormone deficiency in 'little' mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1 or -4. J. Endocrinol. 1993, 136:91-104.
13. Meyer C.W., Korthaus D., Jagla W., et al. A novel missense mutation in the mouse growth hormone gene causes semidominant dwarfism, hyperghrelinemia, and obesity. Endocrinology 2004, 145:2531-2541.
14. List E.O., Palmer A.J., Berryman D.E., Bower B., Kelder B., Kopchick J.J. Growth hormone improves body composition, fasting blood glucose, glucose tolerance and liver triacylglycerol in a mouse model of diet-induced obesity and type 2 diabetes. Diabetologia 2009, 52:1647-1655.
15. Chong P.K., Jung R.T., Scrimgeour C.M., Rennie M.J., Paterson C.R. Energy expenditure and body composition in growth hormone deficient adults on exogenous growth hormone. Clin. Endocrinol. (Oxf.) 1994, 40:103-110.
16. Malmlöf K., Din N., Johansen T., Pedersen S.B. Growth hormone affects both adiposity and voluntary food intake in old and obese female rats. Eur. J. Endocrinol. 2002, 146:121-128.
17. Roberts T.J., Azain M.J. Somatotropin treatment reduces energy intake without altering protein intake in pigs selecting between high and low protein diets. J. Nutr. 1997, 127:2047-2053.
18. Klindt J., Yen J.T., Buonomo F.C., Roberts A.J., Wise T. Growth, body composition, and endocrine responses to chronic administration of insulin-like growth factor I and(or) porcine growth hormone in pigs. J. Anim. Sci. 1998, 76:2368-2381.
19. Azain M.J., Roberts T.J., Martin R.J., Kasser T.R. Comparison of daily versus continuous administration of somatotropin on growth rate, feed intake, and body composition in intact female rats. J. Anim. Sci. 1995, 73:1019-1029.
20. Bohlooly-Y M., Olsson B., Bruder C.E., et al. Growth hormone overexpression in the central nervous system results in hyperphagia-induced obesity associated with insulin resistance and dyslipidemia. Diabetes 2005, 54:51-62.
21. Bengtsson B.A., Brummer R.J., Edén S., Rosén T., Sjöström L. Effects of growth hormone on fat mass and fat distribution. Acta Paediatr. Suppl. 1992, 383:62-65. (discussion 66).
22. Nam S.Y., Kim K.R., Cha B.S., et al. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients. Int. J. Obes. Relat. Metab. Disord. 2001, 25:1101-1107.
23. Pasarica M., Zachwieja J.J., Dejonge L., Redman S., Smith S.R. Effect of growth hormone on body composition and visceral adiposity in middle-aged men with visceral obesity. J. Clin. Endocrinol. Metab. 2007, 92:4265-4270.
24. Flint D.J., Gardner M.J. Influence of growth hormone deficiency on growth and body composition in rats: site-specific effects upon adipose tissue development. J. Endocrinol. 1993, 137:203-211.
25. Alba M., Salvatori R. A mouse with targeted ablation of the growth hormone-releasing hormone gene: a new model of isolated growth hormone deficiency. Endocrinology 2004, 145:4134-4143.
26. Alba M., Fintini D., Salvatori R. Effects of recombinant mouse growth hormone treatment on growth and body composition in GHRH knock out mice. Growth Horm. IGF Res. 2005, 15:275-282.
27. Berryman D.E., List E.O., Kohn D.T., Coschigano K.T., Seeley R.J., Kopchick J.J. Effect of growth hormone on susceptibility to diet-induced obesity. Endocrinology 2006, 147:2801-2808.
28. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
29. Lauterio T.J., Barkan A., DeAngelo M., DeMott-Friberg R., Ramirez R. Plasma growth hormone secretion is impaired in obesity-prone rats before onset of diet-induced obesity. Am. J. Physiol. 1998, 275:E6-E11.
30. Puche R.C., Alloatti R., Chapo G. Growth and development of male "little" mice assessed with Parks' theory of feeding and growth. Growth Dev. Aging 2002, 66:71-78.
31. Flint D.J., Binart N., Boumard S., Kopchick J.J., Kelly P. Developmental aspects of adipose tissue in GH receptor and prolactin receptor gene disrupted mice: site-specific effects upon proliferation, differentiation and hormone sensitivity. J. Endocrinol. 2006, 191:101-111.
32. Berryman D.E., List E.O., Palmer A.J., et al. Two-year body composition analyses of long-lived GHR null mice. J. Gerontol. A Biol. Sci. Med. Sci. 2010, 65:31-40.
33. Egecioglu E., Bjursell M., Ljungberg A., et al. Growth hormone receptor deficiency results in blunted ghrelin feeding response, obesity, and hypolipidemia in mice. Am. J. Physiol. Endocrinol. Metab. 2006, 290:E317-E325.
34. Coschigano K.T., Holland A.N., Riders M.E., List E.O., Flyvbjerg A., Kopchick J.J. Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span. Endocrinology 2003, 144:3799-3810.
35. LaFranchi S., Hanna C.E., Torresani T., Schoenle E., Illig R. Comparison of growth hormone binding and metabolic response in rat adipocytes of epididymal, subcutaneous, and retroperitoneal origin. Acta Endocrinol. (Copenh.) 1985, 110:50-55.
36. Kelder B., Berryman D.E., Clark R., Li A., List E.O., Kopchick J.J. CIDE-A gene expression is decreased in white adipose tissue of growth hormone receptor/binding protein gene disrupted mice and with high-fat feeding of normal mice. Growth Horm. IGF Res. 2007, 17:346-351.
37. Li Y., Knapp J.R., Kopchick J.J. Enlargement of interscapular brown adipose tissue in growth hormone antagonist transgenic and in growth hormone receptor gene-disrupted dwarf mice. Exp. Biol. Med. (Maywood) 2003, 228:207-215.
38. Galic S., Oakhill J.S., Steinberg G.R. Adipose tissue as an endocrine organ. Mol. Cell. Endocrinol. 2010, 316:129-139.
39. Damjanović S.S., Petakov M.S., Raicević S., et al. Serum leptin levels in patients with acromegaly before and after correction of hypersomatotropism by trans-sphenoidal surgery. J. Clin. Endocrinol. Metab. 2000, 85:147-154.
40. Silha J.V., Krsek M., Hana V., et al. Perturbations in adiponectin, leptin and resistin levels in acromegaly: lack of correlation with insulin resistance. Clin. Endocrinol. (Oxf.) 2003, 58:736-742.
41. Kanety H., Hemi R., Ginsberg S., et al. Total and high molecular weight adiponectin are elevated in patients with Laron syndrome despite marked obesity. Eur. J. Endocrinol. 2009, 161:837-844.
42. Oliveira C.R., Salvatori R., Meneguz-Moreno R.A., et al. Adipokine profile and urinary albumin excretion in isolated growth hormone deficiency. J. Clin. Endocrinol. Metab. 2010, 95:693-698.
43. Naderali E.K., Estadella D., Rocha M., et al. A fat-enriched, glucose-enriched diet markedly attenuates adiponectin mRNA levels in rat epididymal adipose tissue. Clin. Sci. (Lond.) 2003, 105:403-408.
44. Rodriguez-Pacheco F., Martinez-Fuentes A.J., Tovar S., et al. Regulation of pituitary cell function by adiponectin. Endocrinology 2007, 148:401-410.
45. Olarescu N.C., Ueland T., Lekva T., et al. Adipocytes as a source of increased circulating levels of nicotinamide phosphoribosyltransferase/visfatin in active acromegaly. J. Clin. Endocrinol. Metab. 2012, 97:1355-1362.
46. Sucunza N., Barahona M.J., Resmini E., et al. A link between bone mineral density and serum adiponectin and visfatin levels in acromegaly. J. Clin. Endocrinol. Metab. 2009, 94:3889-3896.
47. Friebe D., Neef M., Kratzsch J., et al. Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans. Diabetologia 2011, 54:1200-1211.
48. Samal B., Sun Y., Stearns G., Xie C., Suggs S., McNiece I. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol. Cell. Biol. 1994, 14:1431-1437.
49. Garten A., Petzold S., Barnikol-Oettler A., et al. Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is constitutively released from human hepatocytes. Biochem. Biophys. Res. Commun. 2010, 391:376-381.
50. Costford S.R., Bajpeyi S., Pasarica M., et al. Skeletal muscle NAMPT is induced by exercise in humans. Am. J. Physiol. Endocrinol. Metab. 2010, 298:E117-E126.
51. Considine R.V., Sinha M.K., Heiman M.L., et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 1996, 334:292-295.
52. Frederich R.C., Löllmann B., Hamann A., et al. Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity. J. Clin. Invest. 1995, 96:1658-1663.
53. Saad M.F., Khan A., Sharma A., et al. Physiological insulinemia acutely modulates plasma leptin. Diabetes 1998, 47:544-549.
54. Dubuc G.R., Phinney S.D., Stern J.S., Havel P.J. Changes of serum leptin and endocrine and metabolic parameters after 7days of energy restriction in men and women. Metabolism 1998, 47:429-434.
55. Liu J.L., Coschigano K.T., Robertson K., et al. Disruption of growth hormone receptor gene causes diminished pancreatic islet size and increased insulin sensitivity in mice. Am. J. Physiol. Endocrinol. Metab. 2004, 287:E405-E413.
56. Panici J.A., Wang F., Bonkowski M.S., et al. Is altered expression of hepatic insulin-related genes in growth hormone receptor knockout mice due to GH resistance or a difference in biological life spans?. J. Gerontol. A Biol. Sci. Med. Sci. 2009, 64:1126-1133.
57. Zhou Y., Xu B.C., Maheshwari H.G., et al. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc. Natl. Acad. Sci. U. S. A. 1997, 94:13215-13220.
58. Oliveira C.R., Salvatori R., Barreto-Filho J.A., et al. Insulin sensitivity and β-cell function in adults with lifetime, untreated isolated growth hormone deficiency. J. Clin. Endocrinol. Metab. 2012, 97:1013-1019.
59. Guo Y., Lu Y., Houle D., et al. Pancreatic islet-specific expression of an insulin-like growth factor-I transgene compensates islet cell growth in growth hormone receptor gene-deficient mice. Endocrinology 2005, 146:2602-2609.
60. Wang Z., Al-Regaiey K.A., Masternak M.M., Bartke A. Adipocytokines and lipid levels in Ames dwarf and calorie-restricted mice. J. Gerontol. A Biol. Sci. Med. Sci. 2006, 61:323-331.